Back to top
more

Nu Skin Enterprises (NUS)

(Delayed Data from NYSE)

$8.35 USD

8.35
880,682

-0.30 (-3.47%)

Updated Sep 4, 2024 04:00 PM ET

After-Market: $8.35 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 18% (207 out of 251)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

e.l.f. Beauty (ELF) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

e.l.f. Beauty (ELF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Nu Skin's (NUS) Nu Vision 2025 Strategy Bodes Well, Costs Hurt

by Zacks Equity Research

Nu Skin (NUS) benefits from its product launches and Nu Vision 2025 strategy amid challenges like cost inflation and currency volatility.

Nu Skin (NUS) Hurt by Cost Inflation, Adverse Currency Movements

by Zacks Equity Research

Nu Skin (NUS) bears the brunt of COVID-related disruptions, unfavorable currency movements and global inflation.

Why Is Nu Skin (NUS) Down 9.2% Since Last Earnings Report?

by Zacks Equity Research

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Estee Lauder Companies Inc. (EL) Online Sales Aid Growth

by Zacks Equity Research

The Estee Lauder Companies Inc. (EL) is benefiting from a strong online business. It has a solid presence in emerging markets, which bodes well.

Nu Skin (NUS) Q4 Earnings Top Estimates, Sales Down Y/Y

by Zacks Equity Research

Nu Skin's (NUS) fourth-quarter 2022 results reflect lower revenues and earnings on macro headwinds, continued inflation and unfavorable currency.

Nu Skin Enterprises (NUS) Q4 Earnings Surpass Estimates

by Zacks Equity Research

Nu Skin (NUS) delivered earnings and revenue surprises of 67.92% and 3.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin (NUS) Readies for Q4 Earnings: Everything to Note

by Zacks Equity Research

Nu Skin's (NUS) fourth-quarter results are likely to reflect the adverse impacts of cost inflation and currency translations, whereas a focus on the Nu Vision 2025 strategy is likely to have been an upside.

Service Corporation (SCI) Queued for Q4 Earnings: Things to Note

by Zacks Equity Research

Service Corporation's (SCI) fourth-quarter 2022 performance will likely reflect the adverse impact of rising inflationary pressure. Rising corporate general and administrative costs are a concern.

Factors to Watch Ahead of Kraft Heinz's (KHC) Q4 Earnings

by Zacks Equity Research

Kraft Heinz's (KHC) fourth-quarter results are likely to reflect gains from pricing actions and a focus on the operating model amid cost and supply-chain concerns.

Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kellogg (K) Set to Report Q4 Earnings: What Should You Know?

by Zacks Equity Research

Kellogg's (K) fourth-quarter results are likely to reflect strength in the snacks business and emerging markets, whereas cost inflation is likely to have been a concern.

Helen of Troy (HELE) Soars 5.4%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Helen of Troy (HELE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Nu Skin (NUS) Up 28.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Market Edge Highlights: WBA, TROW, ITW, NUS, WSM

by Zacks Equity Research

WBA, TROW, ITW, NUS and WSM have been highlighted in this Market Edge article.

Tracey Ryniec headshot

Looking for High Yields? Check the Dividend Aristocrats

by Tracey Ryniec

Getting a 5% yield isn't easy but here's some tips for finding the stocks.

Nu Skin (NUS) Dips on Q3 Earnings & Revenue Miss, View Cut

by Zacks Equity Research

Nu Skin's (NUS) third-quarter 2022 results are hurt by higher-than-anticipated macro headwinds, continued inflation, and unfavorable currency. Management lowers the full-year view.

Nu Skin Enterprises (NUS) Q3 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Nu Skin (NUS) delivered earnings and revenue surprises of -39.74% and 5.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin (NUS) Queued for Q3 Earnings: Things to Consider

by Zacks Equity Research

Nu Skin's (NUS) Q3 performance will likely reflect continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.

Kellogg's (K) Q3 Earnings Upcoming: Here's All You Should Note

by Zacks Equity Research

Kellogg's (K) third-quarter 2022 results are likely to reflect gains from the company's revenue growth management actions, whereas cost inflation and supply-chain bottlenecks are likely to have been a concern.

Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nu Skin's (NUS) Focus on Nu Vision 2025 & Product Launches Aids

by Zacks Equity Research

Nu Skin (NUS) is optimistic about its Nu Vision 2025 strategy to become the world's leading integrated beauty and wellness company, driven by a dynamic affiliate opportunity platform.

Infosys (INFY) Rides on Digitization Growth and Collaborations

by Zacks Equity Research

Infosys (INFY) continues to gain from its high-margin digital business solutions and back-to-back strategic collaboration wins.

Nu Skin (NUS) Down More Than 15% in 3 Months: Here's Why

by Zacks Equity Research

Nu Skin (NUS) is battling continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.

Nu Skin (NUS) Q2 Earnings Miss Estimates, Trims FY22 View

by Zacks Equity Research

Nu Skin's (NUS) second-quarter 2022 earnings and revenues decline year over year. Management lowers the full year view.